Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Corash

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Blood|January 1, 1991
Multiple in vivo effects of interleukin-3 and interleukin-6 on murine megakaryocytopoiesisP A Carrington, R J Hill, P E Stenberg, et al.
British Journal of Clinical Pharmacology|October 1, 1995
The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humansV Billard, P L Gambus, J Barr, et al.
Vox Sanguinis|February 22, 2017
Red blood cell concentrates treated with the amustaline (S-303) pathogen reduction system and stored for 35 days retain post-transfusion viability: results of a two-centre studyJ A Cancelas, J L Gottschall, N Rugg, et al.
Lancet (London, England)|December 24, 1988
Photochemical decontamination of blood components containing hepatitis B and non-A, non-B virusH J Alter, R P Creagan, P A Morel, et al.
American Journal of Clinical Pathology|October 1, 1994
Flow cytometric reticulocyte analysis. Multiinstitutional interlaboratory correlation studyB H Davis, N C Bigelow, J A Koepke, et al.
Vox Sanguinis|May 23, 2018
Characterization of efficacy and safety of pathogen inactivated and quarantine plasma in routine use for treatment of acquired immune thrombotic thrombocytopenic purpuraR Herbrecht, M Ojeda-Uribe, D Kientz, et al.
Vox Sanguinis|May 19, 2015
A prospective, active haemovigilance study with combined cohort analysis of 19,175 transfusions of platelet components prepared with amotosalen-UVA photochemical treatmentF Knutson, J Osselaer, L Pierelli, et al.
Vox Sanguinis|February 6, 2008
An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatmentJ C Osselaer, J P Cazenave, M Lambermont, et al.
Transfusion|April 1, 1997
Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet lightL Lin, D N Cook, G P Wiesehahn, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Blood|January 1, 1991
Multiple in vivo effects of interleukin-3 and interleukin-6 on murine megakaryocytopoiesisP A Carrington, R J Hill, P E Stenberg, et al.
British Journal of Clinical Pharmacology|October 1, 1995
The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humansV Billard, P L Gambus, J Barr, et al.
Vox Sanguinis|February 22, 2017
Red blood cell concentrates treated with the amustaline (S-303) pathogen reduction system and stored for 35 days retain post-transfusion viability: results of a two-centre studyJ A Cancelas, J L Gottschall, N Rugg, et al.
Lancet (London, England)|December 24, 1988
Photochemical decontamination of blood components containing hepatitis B and non-A, non-B virusH J Alter, R P Creagan, P A Morel, et al.
American Journal of Clinical Pathology|October 1, 1994
Flow cytometric reticulocyte analysis. Multiinstitutional interlaboratory correlation studyB H Davis, N C Bigelow, J A Koepke, et al.
Vox Sanguinis|May 23, 2018
Characterization of efficacy and safety of pathogen inactivated and quarantine plasma in routine use for treatment of acquired immune thrombotic thrombocytopenic purpuraR Herbrecht, M Ojeda-Uribe, D Kientz, et al.
Vox Sanguinis|May 19, 2015
A prospective, active haemovigilance study with combined cohort analysis of 19,175 transfusions of platelet components prepared with amotosalen-UVA photochemical treatmentF Knutson, J Osselaer, L Pierelli, et al.
Vox Sanguinis|February 6, 2008
An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatmentJ C Osselaer, J P Cazenave, M Lambermont, et al.
Transfusion|April 1, 1997
Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet lightL Lin, D N Cook, G P Wiesehahn, et al.
Pageof 11